ID
45816
Beschreibung
Principal Investigator: Carole Ober, PhD, University of Chicago, Chicago, IL, USA MeSH: Fertility,Infertility, Female,Time-to-Pregnancy https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs001146 We performed an unbiased genome-wide expression quantitative trait locus (eQTL) mapping study to identify common regulatory (expression) single nucleotide polymorphisms (eSNPs) in mid-secretory endometrium, corresponding to the luteal phase of the ovarian cycle. Biopsies were collected from 58 women with two or more early pregnancy losses and 53 of these samples passed all quality control. RNA was extracted from endometrial biopsies and DNA was extracted for sequencing from blood. Gene expression data can be found at NCBI GEO Series GSE77688.
Link
Stichworte
Versionen (1)
- 29.06.23 29.06.23 - Simon Heim
Rechteinhaber
Carole Ober, PhD, University of Chicago, Chicago, IL, USA
Hochgeladen am
29. Juni 2023
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY 4.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
dbGaP phs001146 eQTL Mapping of Mid-Secretory Phase Endometrial Cells
Eligibility Criteria
- StudyEvent: SEV1
- Eligibility Criteria
- Subject ID and consent group of participants in mid-secretory endometrium, corresponding to the luteal phase of the ovarian cycle and involved in the "Expression Quantitative Trait Locus Mapping Studies in Mid-Secretory Phase Endometrial Cells Identifies HLA-F and TAP2 as Fecundability-Associated Genes" project.
- Subject ID, sample ID, and sample use variable obtained from participants in mid-secretory endometrium, corresponding to the luteal phase of the ovarian cycle and involved in the "Expression Quantitative Trait Locus Mapping Studies in Mid-Secretory Phase Endometrial Cells Identifies HLA-F and TAP2 as Fecundability-Associated Genes" project.
- Subject ID, age, BMI, race, number of previous miscarriages at time of endometrial biopsy, and time of year of endometrial biopsy of participants in mid-secretory endometrium, corresponding to the luteal phase of the ovarian cycle and involved in the "Expression Quantitative Trait Locus Mapping Studies in Mid-Secretory Phase Endometrial Cells Identifies HLA-F and TAP2 as Fecundability-Associated Genes" project.
- Sample ID, genotyping center, body site where sample was obtained, analyte type, and tumor status of samples obtained from participants in mid-secretory endometrium, corresponding to the luteal phase of the ovarian cycle and involved in the "Expression Quantitative Trait Locus Mapping Studies in Mid-Secretory Phase Endometrial Cells Identifies HLA-F and TAP2 as Fecundability-Associated Genes" project.
Ähnliche Modelle
Eligibility Criteria
- StudyEvent: SEV1
- Eligibility Criteria
- Subject ID and consent group of participants in mid-secretory endometrium, corresponding to the luteal phase of the ovarian cycle and involved in the "Expression Quantitative Trait Locus Mapping Studies in Mid-Secretory Phase Endometrial Cells Identifies HLA-F and TAP2 as Fecundability-Associated Genes" project.
- Subject ID, sample ID, and sample use variable obtained from participants in mid-secretory endometrium, corresponding to the luteal phase of the ovarian cycle and involved in the "Expression Quantitative Trait Locus Mapping Studies in Mid-Secretory Phase Endometrial Cells Identifies HLA-F and TAP2 as Fecundability-Associated Genes" project.
- Subject ID, age, BMI, race, number of previous miscarriages at time of endometrial biopsy, and time of year of endometrial biopsy of participants in mid-secretory endometrium, corresponding to the luteal phase of the ovarian cycle and involved in the "Expression Quantitative Trait Locus Mapping Studies in Mid-Secretory Phase Endometrial Cells Identifies HLA-F and TAP2 as Fecundability-Associated Genes" project.
- Sample ID, genotyping center, body site where sample was obtained, analyte type, and tumor status of samples obtained from participants in mid-secretory endometrium, corresponding to the luteal phase of the ovarian cycle and involved in the "Expression Quantitative Trait Locus Mapping Studies in Mid-Secretory Phase Endometrial Cells Identifies HLA-F and TAP2 as Fecundability-Associated Genes" project.
C0680251 (UMLS CUI [1,2])
C1512693 (UMLS CUI [1,2])
C0043210 (UMLS CUI [1,3])
C4084924 (UMLS CUI [1,4])
C2921106 (UMLS CUI [1,5])
C1510477 (UMLS CUI [2,1])
C0017262 (UMLS CUI [2,2])
C0190979 (UMLS CUI [2,3])
C0012854 (UMLS CUI [2,4])
C0001779 (UMLS CUI [3,1])
C0687675 (UMLS CUI [3,2])
C0032979 (UMLS CUI [3,3])
C1257905 (UMLS CUI [4,1])
C1257906 (UMLS CUI [4,2])
C1257891 (UMLS CUI [4,3])
C1285573 (UMLS CUI [1,2])
C4085938 (UMLS CUI [1,3])
C5239481 (UMLS CUI [1,4])
C1707515 (UMLS CUI [1,5])
C0034378 (UMLS CUI [2,1])
C0752046 (UMLS CUI [2,2])
C1881032 (UMLS CUI [2,3])
C0017270 (UMLS CUI [2,4])
C0043210 (UMLS CUI [3,1])
C2828389 (UMLS CUI [3,2])
C0034378 (UMLS CUI [3,3])
C5200924 (UMLS CUI [3,4])
C0017262 (UMLS CUI [3,5])
C1257905 (UMLS CUI [4,1])
C1257906 (UMLS CUI [4,2])
C4540921 (UMLS CUI [4,3])
Keine Kommentare